Two-year changes in bone mineral density and T scores in patients treated at a pharmacist-run teriparatide clinic.

Study Objectives: To determine changes in bone mineral density (BMD) and T scores of patients after 2 years of teriparatide therapy, and to determine the number of fractures that occurred during therapy.

Design: Prospective, observational study.

Setting: Pharmacist-run teriparatide clinic in a private-practice endocrinology group.

Colesevelam hydrochloride-ezetimibe combination lipid-lowering therapy in patients with diabetes or metabolic syndrome and a history of statin intolerance.

Objective: To determine the effectiveness and safety of colesevelam hydrochloride (HCl) and ezetimibe combination therapy in statin-intolerant patients with dyslipidemia and diabetes mellitus (DM) or metabolic syndrome (MS).

Methods: We identified potential study subjects through a computerized text search of patient electronic medical records using the terms colesevelam, WelChol, ezetimibe, and Zetia. Medical records were subsequently reviewed to identify all patients with DM or MS.

Precision and accuracy of two blood glucose meters: FreeStyle Flash versus One Touch Ultra.

Purpose: The precision and accuracy of two blood glucose meters were evaluated using finger and forearm blood samples.

Methods: Duplicate blood glucose measurements on the same forearm and finger as venipuncture were performed with the FreeStyle Flash and the One Touch Ultra. Accuracy was assessed by error-grid analysis and the number of values within 10% of the laboratory reference value.